Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-25-003850
Filing Date
2025-03-28
Accepted
2025-03-28 13:04:41
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0235539-10k_bioessence.htm   iXBRL 10-K 680751
2 DESCRIPTION OF SECURITIES ea023553901ex4-2_bioess.htm EX-4.2 4696
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES AND EXCHANGE ACT ea023553901ex31-1_bioess.htm EX-31.1 7882
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECURITIES AND EXCHANGE ACT ea023553901ex31-2_bioess.htm EX-31.2 7809
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES AND EXCHANGE ACT ea023553901ex32-1_bioess.htm EX-32.1 4797
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES AND EXCHANGE ACT ea023553901ex32-2_bioess.htm EX-32.2 4935
7 GRAPHIC image_001.jpg GRAPHIC 6343
8 GRAPHIC image_002.jpg GRAPHIC 3779
9 GRAPHIC image_003.jpg GRAPHIC 39447
  Complete submission text file 0001013762-25-003850.txt   4878406

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE bioe-20241231.xsd EX-101.SCH 46878
11 XBRL CALCULATION FILE bioe-20241231_cal.xml EX-101.CAL 78522
12 XBRL DEFINITION FILE bioe-20241231_def.xml EX-101.DEF 221573
13 XBRL LABEL FILE bioe-20241231_lab.xml EX-101.LAB 443315
14 XBRL PRESENTATION FILE bioe-20241231_pre.xml EX-101.PRE 241982
79 EXTRACTED XBRL INSTANCE DOCUMENT ea0235539-10k_bioessence_htm.xml XML 407577
Mailing Address 2955 MAIN STREET STE 300 IRVINE CA 92614
Business Address 2955 MAIN STREET STE 300 IRVINE CA 92614 888-816-1494
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

EIN.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56263 | Film No.: 25783888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)